v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 27, 2024
Sep. 29, 2023
Current assets:    
Cash and cash equivalents $ 482,047 $ 745,364
Restricted cash 95,705 72,602
Short-term investments 0 139,148
Accounts receivable, net of allowance for credit losses of $5,361 and $9,683 315,465 262,245
Contract with Customer, Asset, after Allowance for Credit Loss, Current 197,478 182,130
Inventories 33,728 35,623
Prepaid expenses and other current assets 69,994 50,692
Total current assets 1,194,417 1,487,804
Long-term investments 89,267 97,812
Property, plant and equipment, net 479,109 481,581
Operating lease right-of-use assets 39,046 40,199
Intangible assets, net 434,514 167,427
Goodwill 533,208 408,409
Deferred taxes 219,758 201,860
Other non-current assets 120,609 94,674
Total assets 3,109,928 2,979,766
Current liabilities:    
Accounts payable 17,380 20,925
Accrued liabilities 347,529 351,399
Income taxes payable 9,045 4,769
Contract liabilities 31,644 31,505
Operating lease liabilities 12,238 13,628
Total current liabilities 417,836 422,226
Non-current contract liabilities 34,593 39,997
Non-current operating lease liabilities 34,754 37,020
Other non-current liabilities 135,852 108,339
Total liabilities 623,035 607,582
Stockholders' equity:    
Retained earnings 2,496,255 2,391,990
Accumulated other comprehensive income (19,187) (36,984)
Total stockholders’ equity – Dolby Laboratories, Inc. 2,477,162 2,355,100
Controlling interest 9,731 17,084
Total stockholders’ equity 2,486,893 2,372,184
Total liabilities and stockholders’ equity 3,109,928 2,979,766
Class A Common Stock [Member]    
Stockholders' equity:    
Common stock 53 53
Class B Common Stock [Member]    
Stockholders' equity:    
Common stock $ 41 $ 41